Latest Insider Transactions at I Teos Therapeutics, Inc. (ITOS)
This section provides a real-time view of insider transactions for I Teos Therapeutics, Inc. (ITOS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of iTeos Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of iTeos Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,913
-0.15%
|
$132,651
$27.81 P/Share
|
|
Sep 24
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,089
-1.09%
|
$30,492
$28.02 P/Share
|
|
Sep 24
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,221
-0.15%
|
$221,967
$27.81 P/Share
|
|
Sep 23
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,930
-0.55%
|
$1,034,040
$28.17 P/Share
|
|
Sep 23
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,930
-0.55%
|
$1,034,040
$28.17 P/Share
|
|
Sep 23
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,322
-5.05%
|
$149,016
$28.16 P/Share
|
|
Sep 23
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
61,800
-0.56%
|
$1,730,400
$28.17 P/Share
|
|
Sep 22
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,294
-0.42%
|
$385,938
$27.54 P/Share
|
|
Sep 22
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,294
-0.42%
|
$385,938
$27.54 P/Share
|
|
Sep 22
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
23,921
-0.43%
|
$645,867
$27.54 P/Share
|
|
Sep 21
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,635
-0.58%
|
$530,145
$27.47 P/Share
|
|
Sep 21
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,635
-0.58%
|
$530,145
$27.47 P/Share
|
|
Sep 21
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,858
-0.59%
|
$887,166
$27.47 P/Share
|
|
Sep 20
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,303
-0.36%
|
$656,181
$27.44 P/Share
|
|
Sep 20
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,303
-0.36%
|
$656,181
$27.44 P/Share
|
|
Sep 20
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,673
-0.36%
|
$1,098,171
$27.44 P/Share
|
|
Sep 17
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,698
-1.32%
|
$1,279,544
$28.82 P/Share
|
|
Sep 17
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,698
-1.32%
|
$1,279,544
$28.82 P/Share
|
|
Sep 17
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
76,473
-1.34%
|
$2,141,244
$28.82 P/Share
|
|
Sep 16
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,253
-0.61%
|
$595,084
$28.47 P/Share
|
|
Sep 16
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,253
-0.61%
|
$595,084
$28.47 P/Share
|
|
Sep 16
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,565
-0.62%
|
$995,820
$28.47 P/Share
|
|
Sep 15
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,104
-0.34%
|
$650,808
$27.97 P/Share
|
|
Sep 15
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,104
-0.34%
|
$650,808
$27.97 P/Share
|
|
Sep 15
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,336
-0.35%
|
$1,089,072
$27.97 P/Share
|
|
Sep 14
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,561
-0.31%
|
$582,147
$27.75 P/Share
|
|
Sep 14
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,561
-0.31%
|
$582,147
$27.75 P/Share
|
|
Sep 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,081
-0.31%
|
$974,187
$27.75 P/Share
|
|
Sep 13
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,384
-0.6%
|
$577,368
$27.64 P/Share
|
|
Sep 13
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,384
-0.6%
|
$577,368
$27.64 P/Share
|
|
Sep 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,785
-0.61%
|
$966,195
$27.64 P/Share
|
|
Sep 10
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,531
-0.19%
|
$378,868
$28.3 P/Share
|
|
Sep 10
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,531
-0.19%
|
$378,868
$28.3 P/Share
|
|
Sep 10
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,643
-0.19%
|
$634,004
$28.3 P/Share
|
|
Sep 09
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,725
-0.63%
|
$636,300
$28.97 P/Share
|
|
Sep 09
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,725
-0.63%
|
$636,300
$28.97 P/Share
|
|
Sep 09
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
38,028
-0.64%
|
$1,064,784
$28.97 P/Share
|
|
Sep 08
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,092
-0.17%
|
$338,576
$28.86 P/Share
|
|
Sep 08
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,092
-0.17%
|
$338,576
$28.86 P/Share
|
|
Sep 08
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,236
-0.17%
|
$566,608
$28.86 P/Share
|
|
Sep 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
31,340
-0.86%
|
-
|
|
Sep 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,474
-0.83%
|
$883,746
$29.18 P/Share
|
|
Sep 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
31,340
-0.86%
|
-
|
|
Sep 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,474
-0.83%
|
$883,746
$29.18 P/Share
|
|
Sep 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
31,340
-0.53%
|
-
|
|
Sep 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,996
-0.85%
|
$1,478,884
$29.18 P/Share
|
|
Sep 02
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,568
-4.97%
|
$335,472
$29.2 P/Share
|
|
Sep 01
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,684
-6.91%
|
$243,152
$28.3 P/Share
|
|
Aug 31
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,093
-3.15%
|
$114,604
$28.12 P/Share
|
|
Aug 30
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,322
-1.76%
|
$65,016
$28.01 P/Share
|